Identification of critical antigen-specific mechanisms in the development of immune thrombocytopenic purpura in mice

Blood

Volumn 96, Issue 7, 2000, Pages 2520-2527

  Nieswandt, B ^a   Bergmeier, W ^a   Rackebrandt, K ^a   Engelbert Gessner, J ^a   Zirngibl, H ^a  

^a UNIVERSITY OF WITTEN HERDECKE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD31 ANTIGEN; FIBRINOGEN RECEPTOR; GLYCOPROTEIN; GLYCOPROTEIN IIIA; GLYCOPROTEIN V; IMMUNOGLOBULIN F(AB) FRAGMENT; IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY; THROMBIN RECEPTOR; THROMBOCYTE ACTIVATING FACTOR RECEPTOR; THROMBOCYTE ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLEEDING; CELL DESTRUCTION; CONTROLLED STUDY; FEMALE; HEMATOCRIT; HYPOTHERMIA; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IN VIVO STUDY; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; THROMBOCYTE COUNT;

EID: 0034307371     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v96.7.2520     Document Type: Article

References (28)

1. The cellular immunology associated with autoimmune thrombocytopenic purpura: An update
2. Platelet autoantibodies in immune thrombocytopenic purpura
3. Autoimmune thrombocytopenic purpura (AITP) and acquired thrombasthenia due to autoantibodies to GP IIb-IIIa in a patient with an unusual platelet membrane glycoprotein composition
4. Acquired thrombasthenia due to GPIIb/IIIa-specific platelet autoantibodies
5. Autoantibody against platelet glycoprotein IIb/IIIa in a patient with non-Hodgkin's lymphoma
6. Acquired disorder of platelet function associated with autoantibodies against membrane glycoprotein IIb-IIIa complex-1: Glycoprotein analysis
7. Defect of platelet aggregation and adhesion induced by autoantibodies against platelet glycoprotein IIIa
8. Functional studies on platelets of a patient with an acquired disorder of platelet function associated with autoantibodies against membrane glycoprotein IIB/IIIA complex
9. Management of chronic autoimmune thrombocytopenic purpura (ITP) in adults
10. Management of chronic refractory idiopathic thrombocytopenic purpura
11. Idiopathic thrombocytopenic purpura: A practice guideline developed by explicit methods for the American Society of Hematology
12. Development and characterization of monoclonal antiplatelet autoantibodies from auto-immune thrombocytopenic purpura-prone (NZW x BXSB)F1 mice
13. Acute systemic reaction and lung alterations induced by an antiplatelet integrin gpIIb/IIIa antibody in mice
14. Carboxypeptidase M is identical to the MAX. 1 antigen and its expression is associated with monocyte to macrophage differentiation
15. Structural and functional characterization of the mouse von Willebrand factor receptor complex GPIb-IX with novel monoclonal antibodies
16. Platelet-activating factor produces shock, in vivo complement activation, and tissue injury in mice
17. Platelet-activating factor is a mediator in tumor necrosis factor/galactosamine-induced lethality
18. Relative antithrombotic effects of monoclonal antibodies targeting different platelet glycoprotein-adhesive molecule interactions in nonhuman primates
19. Intravenous immunoglobulin and anti-D in idiopathic thrombocytopenic purpura (ITP): Mechanisms of action
20. Autoantibodies against platelet glycoprotein Ib in patients with chronic immune thrombocytopenic purpura
21. Autoantibodies against the platelet glycoprotein IIb/IIIa complex in patients with chronic ITP
22. Autoantibodies to the presumptive cytoplasmic domain of platelet glycoprotein IIIa in patients with chronic immune thrombocytopenic purpura
23. Reactivity of autoantibodies from chronic ITP patients with recombinant glycoprotein IIIa peptides
24. Fc receptors
25. Impaired IgG-dependent anaphylaxis and Arthus reaction in Fc gamma RIII (CD16) deficient mice
26. Platelet-derived microparticle formation involves glycoprotein IIb-IIIa: Inhibition by RGDS and a Glanzmann's thrombasthenia defect
27. Analysis of the tetraspanin CD9-integrin alphaIIbbeta3 (GPIIb-IIIa) complex in platelet membranes and transfected cells
28. Failure of the platelet-activating factor antagonist WEB 2086 BS for treatment of chronic autoimmune thrombocytopenia